Revenue: The sum of all revenue fields included for a company's operating activities.
Coherus BioSciences, Inc. (CHRS) had Revenue of $7.60M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$7.60M |
$-56.57M |
|
$2.65M |
|
$4.95M |
|
$53.03M |
|
$-45.44M |
|
$-1.96M |
|
$-47.40M |
|
$-47.40M |
|
$-47.40M |
|
$-47.40M |
|
$-56.57M |
|
$-47.40M |
|
$-45.44M |
|
$-44.39M |
|
115.86M |
|
115.86M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$310.18M |
|
$2.26M |
|
$60.89M |
|
$371.07M |
|
$255.04M |
|
$265.35M |
|
$299.49M |
|
$554.54M |
|
$-183.47M |
|
$-236.45M |
|
$-183.47M |
|
115.91M |
|
| Cash Flow Statement Financials | |
$-25.83M |
|
$-17.49M |
|
$-0.26M |
|
$126.25M |
|
$82.67M |
|
$-43.58M |
|
$5.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.22 |
|
-- |
|
-- |
|
3.24 |
|
-1.45 |
|
65.09% |
|
-597.91% |
|
-597.91% |
|
-- |
|
-623.74% |
|
-744.43% |
|
$-25.83M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.75 |
|
0.12 |
|
739.47 |
|
25.83% |
|
20.05% |
|
-12.77% |
|
-57.89% |
|
$-1.58 |
|
$-0.22 |
|
$-0.22 |
|